Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idex (IEX) Gains from Investment Securities (2016 - 2025)

Idex (IEX) has disclosed Gains from Investment Securities for 17 consecutive years, with -$300000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Gains from Investment Securities rose 40.0% to -$300000.0 in Q2 2025 year-over-year; TTM through Sep 2025 was $2.9 million, a 31.82% increase, with the full-year FY2023 number at -$3.5 million, up 52.05% from a year prior.
  • Gains from Investment Securities was -$300000.0 for Q2 2025 at Idex, down from -$100000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $5.4 million in Q1 2021 to a low of -$6.9 million in Q3 2022.
  • A 5-year average of -$350000.0 and a median of -$450000.0 in 2022 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: crashed 4900.0% in 2022, then surged 273.68% in 2024.
  • Idex's Gains from Investment Securities stood at $3.7 million in 2021, then crashed by 113.51% to -$500000.0 in 2022, then fell by 20.0% to -$600000.0 in 2023, then skyrocketed by 650.0% to $3.3 million in 2024, then plummeted by 109.09% to -$300000.0 in 2025.
  • Per Business Quant, the three most recent readings for IEX's Gains from Investment Securities are -$300000.0 (Q2 2025), -$100000.0 (Q1 2025), and $3.3 million (Q3 2024).